Indirect immunofluorescence reaction study of systemic and local humoral immunity in patients with chronic inflammatory lung disease. I. Serological study results with Streptococcus pneumoniae autostrains
Abstract
In the serological study of chronic bronchitis at the stage of exacerbation, carried out by means of the indirect immunofluorescence test with the use of Str. pneumoniae autostrains, 90.3 +/- 4% of the patients showed correlation between the presence of pneumococci in the bronchial contents and the systemic immunological reaction to this infective agent. At the acute stage of chronic bronchitis high antibody titers (1 : 1280 - 1 : 5120) prevailed, and the repeated study revealed the 4-fold and greater growth of the initial antibody titers in 35.7 +/- 6.4% of the patients. Antipneumococcal immunity in chronic bronchitis was found to have a pronounced type-specific character.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.